This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Medimmune Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Guoling Xi: Innovator in Immunoconjugate Production
Introduction
Guoling Xi is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of immunoconjugates, particularly through his innovative methods that enhance the production of these vital compounds.
Latest Patents
Guoling Xi holds a patent for "Methods of producing immunoconjugates." This invention provides methods for preparing active immunoconjugates, including anti-CD22 immunoconjugates. The methods involve a fed-batch refolding process and/or column stripping process, which significantly increases the yield of the immunoconjugate compared to other processes that do not utilize these methods. He has 1 patent to his name.
Career Highlights
Guoling Xi is currently employed at MedImmune Limited, where he continues to work on advancing the field of immunoconjugates. His expertise and innovative approaches have positioned him as a valuable asset in the biotechnology sector.
Collaborations
Throughout his career, Guoling Xi has collaborated with notable colleagues, including Alan Hunter and Andrew Fulton. These collaborations have further enriched his work and contributed to the development of groundbreaking technologies in immunotherapy.
Conclusion
Guoling Xi's contributions to the field of immunoconjugates exemplify the impact of innovative thinking in biotechnology. His methods not only enhance production efficiency but also pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile